MYONEX NEWS

Tom Gregson, VP of Business Development, to host Top Clinical Trial Supply Trends of 2024 Webinar

As the life sciences industry continues to rapidly evolve, sponsors, clinical research organizations (CROs) and trial sites face new challenges as well as opportunities in 2024. This webinar is designed to provide industry leaders with a deep dive into the most critical clinical trial supply trends and the strategies needed to navigate each effectively.

“Clinical Supply strategies and site dependency can drastically impact First Patient In timelines and retention efforts throughout the trial duration.”

Tom Gregson, Vice President of Business Development

The top clinical trial supply trends for 2024 include:

1. Continued patient focus — recruitment is only the beginning, and the entire patient experience leads to higher retention. One of the biggest focuses of clinical trials is on the patient — from recruitment to retention, these elements of a trial quickly become key success factors. Clinical Supply strategies and site dependency can drastically impact First Patient In timelines and retention efforts throughout the trial duration.
2. Cost control — reduce drug waste without compromising on missed doses.
   How can you free up dollars within your study without compromising on the quality? What other areas can you now apply this money to? This section allows you to see how to approach and manage trial supply elements to accomplish less waste and secure fewer drop-outs.
3. Shortened start-up timelines — supplies meeting the demands of Clinical First Patient In.
   The featured speaker will discuss the strategies available to accelerate the ability to meet First Patient In and ensure the rest of a trial stays on time.
4. Vendor consolidation — reduce the number of vendors and complexity.
   Managing multiple vendors and the dependency on them to cross-communicate and deliver on time requires you to be in control and accountable — even for things out of your control. Learn how to reduce that dependency and complexity.
5. Complex trial designs — multiple treatment arms, physicians’ choice, dose escalation, umbrella or basket trial designs. A trend that is only on the rise, learn strategies to ensure these trial designs do not delay a trial or complicate overall trial management.
6. Increased diversity, equity and inclusion (DEI) — including removal of financial barriers/insurance co-pays to enhance study recruitment and retention. We will address the essential aspect of diversity, equity, and inclusion (DEI) in clinical trials considering the US Food and Drug Administration’s (FDA’s) guidance. The focus will be on removing financial barriers, such as insurance co-pays, to enhance study recruitment and increase retention.
7. Decentralized clinical trials with direct-to-patient (DCT/DTP) — gaining importance in trials.
   Hybrid approaches to clinical trials only further push the focus around patient-centric trials. DCT and DTP approaches allow for further engagement from trial participants and offer convenience, potentially increasing patient recruitment and retention.

Related Reading from LEK Consulting
Explore a transformative approach to patient recruitment and retention in clinical trials with a thought-provoking white paper by LEK Consulting. Uncover how covering standard-of-care medication costs can not only accelerate enrollment but also promote diversity, equity, and inclusion by removing financial barriers for uninsured and underinsured participants. This strategic shift can lead to more efficient and inclusive trials, aligning perfectly with the focus on patient-centric approaches in 2024.

Read White Paper